249 related articles for article (PubMed ID: 27142473)
1. Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine.
Maagdenberg H; Vijverberg SJ; Bierings MB; Carleton BC; Arets HG; de Boer A; Maitland-van der Zee AH
Paediatr Drugs; 2016 Aug; 18(4):251-60. PubMed ID: 27142473
[TBL] [Abstract][Full Text] [Related]
2. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.
Ortega VE; Meyers DA
J Allergy Clin Immunol; 2014 Jan; 133(1):16-26. PubMed ID: 24369795
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of asthma: toward precision medicine.
Kersten ET; Koppelman GH
Curr Opin Pulm Med; 2017 Jan; 23(1):12-20. PubMed ID: 27764000
[TBL] [Abstract][Full Text] [Related]
5. The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.
Ross CJ; Visscher H; Sistonen J; Brunham LR; Pussegoda K; Loo TT; Rieder MJ; Koren G; Carleton BC; Hayden MR;
Thyroid; 2010 Jul; 20(7):681-7. PubMed ID: 20578893
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
Becquemont L
Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
[TBL] [Abstract][Full Text] [Related]
7. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
[TBL] [Abstract][Full Text] [Related]
8. Treatment response heterogeneity in asthma: the role of genetic variation.
Vijverberg SJH; Farzan N; Slob EMA; Neerincx AH; Maitland-van der Zee AH
Expert Rev Respir Med; 2018 Jan; 12(1):55-65. PubMed ID: 29115880
[TBL] [Abstract][Full Text] [Related]
9. Expanding role of pharmacogenomics in the management of cardiovascular disorders.
Yip VL; Pirmohamed M
Am J Cardiovasc Drugs; 2013 Jun; 13(3):151-62. PubMed ID: 23579966
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of long-acting β2-agonists.
Blake K; Lima J
Expert Opin Drug Metab Toxicol; 2015; 11(11):1733-51. PubMed ID: 26235677
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review.
Slob EMA; Vijverberg SJH; Palmer CNA; Zazuli Z; Farzan N; Oliveri NMB; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH
Pediatr Allergy Immunol; 2018 Nov; 29(7):705-714. PubMed ID: 29992699
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.
Hernandez W; Gamazon ER; Aquino-Michaels K; Smithberger E; O'Brien TJ; Harralson AF; Tuck M; Barbour A; Cavallari LH; Perera MA
J Thromb Haemost; 2017 Apr; 15(4):735-743. PubMed ID: 28135054
[TBL] [Abstract][Full Text] [Related]
13. Dosing algorithms for vitamin K antagonists across VKORC1 and CYP2C9 genotypes.
Baranova EV; Verhoef TI; Ragia G; le Cessie S; Asselbergs FW; de Boer A; Manolopoulos VG; Maitland-van der Zee AH;
J Thromb Haemost; 2017 Mar; 15(3):465-472. PubMed ID: 28063245
[TBL] [Abstract][Full Text] [Related]
14. Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital.
La Russa R; Fineschi V; Di Sanzo M; Gatto V; Santurro A; Martini G; Scopetti M; Frati P
Curr Pharm Biotechnol; 2017; 18(3):274-281. PubMed ID: 28176638
[TBL] [Abstract][Full Text] [Related]
15. Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update.
Scott EN; Joseph AA; Dhanda A; Tanoshima R; Brooks B; Rassekh SR; Ross CJD; Carleton BC; Loucks CM
Ther Drug Monit; 2023 Dec; 45(6):714-730. PubMed ID: 37726872
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Arg16Gly in
Li X; Cao Y
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(8):891-899. PubMed ID: 37256257
[TBL] [Abstract][Full Text] [Related]
17. Review on Pharmacogenetics and Pharmacogenomics Applied to the Study of Asthma.
Sánchez-Martín A; García-Sánchez A; Isidoro-García M
Methods Mol Biol; 2016; 1434():255-72. PubMed ID: 27300544
[TBL] [Abstract][Full Text] [Related]
18. The role of pharmacogenomics in adverse drug reactions.
Cacabelos R; Cacabelos N; Carril JC
Expert Rev Clin Pharmacol; 2019 May; 12(5):407-442. PubMed ID: 30916581
[TBL] [Abstract][Full Text] [Related]
19. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
